AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-112991488/fda-approves-zyprexa-delay.html" title="Facts and information about FDA approves Zyprexa to delay relapse into mania, depression.">FDA approves Zyprexa to delay relapse into mania, depression.</a>

Close Set up an RSS feed that alerts you when new articles from Drug Week are available.

Frequently asked questions about RSS feeds

FDA approves Zyprexa to delay relapse into mania, depression.

Drug Week

| February 13, 2004 | COPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 FEB 13 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved Zyprexa (olanzapine) for maintenance in the treatment of bipolar disorder, Eli Lilly and Co. announced.

This FDA approval recognizes that Zyprexa is an effective treatment to delay relapse into either mania or depression in patients with bipolar disorder.

Zyprexa is the first treatment in nearly 30 years to be recognized by the FDA as a treatment for both acute mania and maintenance treatment in bipolar disorder.

"Bipolar disorder is a serious condition that can be difficult to treat. For those who achieve stability on existing medications, relapse…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Both lamotrigine, lithium delay relapse of bipolar disorder. (Two...: Magazine article from: Clinical Psychiatry News Boschert, Sherry October 1, 2002 700+ words
YOKOHAMA, JAPAN -- Two of the longest studies of maintenance therapy for bipolar disorder found that both lithium and the antiepileptic drug lamotrigine delayed relapse, with lithium predominantly preventing manic episodes...


FDA Approves Zyprexa for Bipolar Disorder.: Press release article from: PR Newswire January 15, 2004 700+ words
...treatment to delay relapse into either...patients with bipolar disorder. Zyprexa is...associated with bipolar disorder and is the first...acute mania and delay relapse of symptoms associated with bipolar disorder since lithium...


FDA Approves Zyprexa(R) for Maintenance of Bipolar Disorder; First Atypical...: Press release article from: PR Newswire January 14, 2004 700+ words
...treatment to delay relapse into either...patients with bipolar disorder. Zyprexa is...associated with bipolar disorder and is the first...acute mania and delay relapse of symptoms associated with bipolar disorder since lithium...


Multimedia News Release - FDA Approves Zyprexa(R) for Maintenance of Bipolar...: Press release article from: PR Newswire January 15, 2004 700+ words
...treatment to delay relapse into either...patients with bipolar disorder. Zyprexa is...associated with bipolar disorder and is the first...acute mania and delay relapse of symptoms associated with bipolar disorder since lithium...


FDA approves Zyprexa to delay relapse into mania, depression.: Newspaper article from: Biotech Business Week February 9, 2004 700+ words
...treatment to delay relapse into either...patients with bipolar disorder. Zyprexa is...associated with bipolar disorder and is the first...acute mania and delay relapse of symptoms associated with bipolar disorder since lithium...


Lilly: Landmark, Placebo-Controlled Trial Suggests Olanzapine May Delay and...: Press release article from: Business Wire May 19, 2003 700+ words
...Devastating to People With Bipolar Disorder A landmark, placebo...depressive episodes of bipolar disorder. Olanzapine is the only...demonstrate that it may delay relapse to both poles of bipolar disorder in a placebo-controlled...


FDA approves Zyprexa for maintenance of bipolar disorder.: News wire article from: Asia Africa Intelligence Wire January 14, 2004 700+ words
...the treatment of bipolar disorder, Eli Lilly and...effective treatment to delay relapse into either mania...in patients with bipolar disorder. In addition to...associated with bipolar disorder. Headquartered...


Multimedia News Release - FDA approves Zyprexa for maintenance of bipolar...: News wire article from: Asia Africa Intelligence Wire January 15, 2004 700+ words
...the treatment of bipolar disorder, Eli Lilly and...effective treatment to delay relapse into either mania...in patients with bipolar disorder. Zyprexa is the...maintenance treatment in bipolar disorder. Headquartered...


Bipolar disorder risks revealed.: News wire article from: UPI Health Business May 22, 2006 700+ words
...toward them may be exhibiting signs of bipolar disorder, researchers reported Monday. Other...include anxiety, a family history of bipolar disorder, a recent diagnosis of depression...three of these risk factors also had bipolar disorder, an illness marked by severe mood...


2007 Bipolar Disorder Awareness Campaign Emphasizes Importance of Accurate...: Press release article from: PR Newswire October 11, 2007 700+ words
...Mental Illness Launches 5th Annual Bipolar Disorder Awareness Day WASHINGTON, Oct. 11...today launched its fifth annual Bipolar Disorder Awareness Day, emphasizing the need...treatment. People diagnosed with bipolar disorder, which affects an estimated 10 million...

For more facts and information, see all results

Source: HighBeam Research, FDA approves Zyprexa to delay relapse into mania, depression.

The AccessMyLibrary advertising network includes: